Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Montserrat Arnan
Dasatinib as Salvage Therapy for Steroid Refractory and Imatinib Resistant or Intolerant Sclerotic Chronic Graft-Versus-Host Disease
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Related publications
Imatinib Mesylate for the Treatment of Steroid-Refractory Sclerotic-Type Cutaneous Chronic Graft-Versus-Host Disease
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Cost-Effectiveness of Dasatinib and Nilotinib for Imatinib-Resistant or -Intolerant Chronic Phase Chronic Myeloid Leukemia
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Tocilizumab for Steroid Refractory Acute Graft-Versus-Host Disease
Leukemia and Lymphoma
Cancer Research
Oncology
Hematology
Late Onset and Protracted Course of Steroid Refractory Chronic Graft-Versus-Host Disease
Case Reports in Hematology
Combination of Bortezomib Plus Ruxolitinib in Steroid-Refractory Chronic Graft-Versus-Host Disease
Bone Marrow Transplantation
Transplantation
Hematology
Response to Thalidomide Therapy in Refractory Chronic Graft-Versus-Host Disease
Bone Marrow Transplantation
Transplantation
Hematology
Sirolimus for Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease
Bone Marrow Transplantation
Transplantation
Hematology
Phase II Pilot Study of Imatinib Mesylate for the Treatment of Severe Sclerotic Skin Chronic Graft Versus Host Disease (ScGVHD)
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Rituximab Provides Steroid-Sparing Therapy in New-Onset Chronic Graft-Versus-Host Disease
Biology of Blood and Marrow Transplantation
Transplantation
Hematology